E. Anne Davis, PharmD, MS

home / authors / e-anne-davis-pharmd-ms

Articles

May 1st 2008

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

Muta M. Issa, MD, MBA Pei-Jung Lin, PhD Michael T. Eaddy, PharmD, PhD Manan B. Shah, PharmD, PhD E. Anne Davis, PharmD, MS

May 1st 2008

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

Thomas C. Fenter, MD E. Anne Davis, PharmD, MS Manan B. Shah, PharmD, PhD Pei-Jung Lin, PhD

March 1st 2006

An Examination of Treatment Patterns and Costs of Care Among Patients With Benign Prostatic Hyperplasia

Libby Black, PharmD Michael James Naslund, MD, MBA Thomas D. Gilbert, Jr, MS E. Anne Davis, PharmD, MS Daniel A. Ollendorf, MPH

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

ICYMI: Highlights From IMS 2024

Published: December 17th 2024 | Updated: December 22nd 2024

ICYMI: Highlights From IMS 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions